The WTA just dropped a bombshell: all players must now undergo genetic sex screening to stay on tour, checking for the SRY gene via a simple swab or blood test — a move that puts them ahead of the curve, aligning with Olympic standards. While some scientists, like the gene’s discoverer, argue it’s overly simplistic, the policy’s real aim is clear: to preserve fair competition. Experts say athletes assigned male at birth retain physical advantages even after hormone therapy, making this screening a necessary safeguard for athletic integrity. But the “why” behind the timing and rollout remains murky — is it player-driven, strategic, or just a knee-jerk response to the culture war? The debate is fierce, and the stakes couldn’t be higher.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
